The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEast Imperial Regulatory News (EISB)

  • This share is currently suspended. It was suspended at a price of 0.28

Share Price Information for East Imperial (EISB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.28
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.28
EISB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Completion - Secured Convertible Loan Notes

14 Aug 2023 12:54

RNS Number : 2560J
East Imperial PLC
14 August 2023
 

East Imperial plc

(the "Company")

First Completion - 10% Secured Convertible Loan Notes ("2025 Convertible Loan Notes")

East Imperial, the global purveyor of ultra-premium beverages, is pleased to announce that following the passing of the resolutions at the Company's General Meeting held on 4 August 2023 it has now issued £1,466,666.67 of 2025 Convertible Loan Notes to INL Investment Limited in accordance with the Conditional Loan Note Subscription Agreement dated 17 July 2023 ("Subscription Agreement") between the Company and INL Investment Limited ("First Completion").

The 2025 Convertible Loan Notes are secured by way of a debenture which contains fixed and floating charges over the assets of the Company. It is the parties' intention that security will shortly be granted over the Company's wholly owned Singapore incorporated subsidiary; and a charge will be granted by the Company's chief executive officer, Tony Burt, over 47,645,448 ordinary shares of £0.01 each in the capital of the Company ("Ordinary Shares") held by him representing 14.1 per cent. of the issued share capital.

 

INL Investment Limited has the right to convert the 2025 Convertible Loan Notes, including the rolled-up 10% interest thereon, into Ordinary Shares at a price equal to a 20% discount to the 60 day VWAP of the Ordinary Shares as at the date of the conversion notice, subject to a minimum price per Ordinary Share of £0.01 (being the nominal value of the Ordinary Shares) (the "Conversion Price"), at any time after the expiry of the 12 month period commencing on the date of the instrument constituting the 2025 Convertible Loan Notes ("Convertible Loan Note Instrument") until the redemption of the 2025 Convertible Loan Notes in accordance with the terms of the Convertible Loan Note Instrument. The maturity date of the 2025 Convertible Loan Notes is the first business day falling twenty-four months after the date of issue of the relevant 2025 Convertible Loan Notes.

Under the terms of the Subscription Agreement INL Investment Limited will subscribe for a further £733,333.33 of 2025 Convertible Loan Notes under the second tranche of the investment ("Second Completion"), which is expected to take place on the first business day falling three (3) calendar months following First Completion. A further announcement will be made by the Company in due course.

No application will be made for the admission of the 2025 Convertible Loan Notes to trading on any recognised securities exchange.

 

Enquiries

East Imperial Plc

Antony Burt / Andrew Robertson - investors@eastimperial.com

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMRMDZGFZM
12
Date   Source Headline
15th Apr 20247:57 amRNSSuspension of Share Trading
15th Apr 20247:30 amRNSSuspension - East Imperial plc
12th Apr 20244:42 pmRNSCorporate Update
11th Apr 20243:27 pmRNSUpdate re. potential funding sources
11th Apr 20247:00 amRNSResignation of Director
6th Mar 20247:00 amRNSInterview with Chief Executive Officer, Tony Burt
29th Feb 20249:32 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSDirectorsTalk Interview
22nd Feb 20247:00 amRNSYear-End Trading Update
19th Feb 20246:07 pmRNSResult of General Meeting
13th Feb 20247:00 amRNSContinued Global Account Wins in 2024
5th Feb 20247:00 amRNSPartnership with Galaxy Entertainment Group
2nd Feb 202412:19 pmRNSNotice of GM and Capital Reorganisation
2nd Feb 20247:00 amRNSManagement and Board changes
31st Jan 20245:00 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNSHolding(s) in Company
24th Jan 20247:50 amRNSProposed Placing to raise approximately £325,000
3rd Jan 20247:00 amRNSNew Zealand Trading Update
13th Dec 20237:16 amRNSHolding(s) in Company
8th Dec 20237:00 amRNSAppointment of Allenby Capital as Broker
13th Nov 20238:02 amRNSDirectorship Changes
7th Nov 20237:05 amRNSDirectorsTalk Interview
7th Nov 20237:00 amRNSSecond Completion - Secured Convertible Loan Notes
29th Sep 20237:10 amRNSInterim Results
29th Sep 20237:00 amRNSPartnership Agreement
6th Sep 20238:13 amRNSDirectorship Changes
22nd Aug 20237:14 amRNSAppointment of Key US Sales Resource
15th Aug 20237:40 amRNSHolding(s) in Company
14th Aug 202312:54 pmRNSFirst Completion - Secured Convertible Loan Notes
14th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20238:46 amRNSHolding(s) in Company
4th Aug 202311:18 amRNSResult of General Meeting
28th Jul 20237:00 amRNSAir New Zealand Partnership
19th Jul 202312:25 pmRNSNotice of GM
17th Jul 20237:00 amRNSFunding Update – issue of £2.2m Convertible Loan
30th Jun 202310:13 amRNSResult of AGM
6th Jun 20237:55 amRNSPosting of Annual Report and Notice of AGM
2nd May 20237:00 amRNSAudited Full-Year Results
13th Apr 20237:00 amRNSBoard Change
17th Feb 202310:26 amRNSHolding(s) in Company
9th Feb 20232:05 pmRNSSecond Price Monitoring Extn
9th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSPre-Close Trading Statement
13th Jan 202310:00 amRNSTR-1: Notification of Major Holdings
8th Dec 20227:00 amRNSVietnam Distribution Agreement
24th Nov 20229:06 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.